FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/09/057620 [Registered on: 14/09/2023] Trial Registered Prospectively
Last Modified On: 25/08/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   This Clinical Trial is intented to compare the efficacy of Mukhadushikahara Acne Patch with Mukhadushikahara lepa along with Triphaladi Kashaya intenally in the management of Acne Vulgaris. 
Scientific Title of Study   Critical Study of Tistraishaniya Adhyaya of Charaka Samhita w.s.r. to Bahiparimarjana Chikitsa and Comparative Clinical Efficacy of Mukhadushikahara Acne Patch and Mukhadushikahara Lepa along with Triphaladi Kashaya in the management of Mukhadushika (Acne Vulgaris)  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rananavare Dipa Shivaji 
Designation  PhD Scholar, Institute of Teaching and Research in Ayurveda, Jamnagar 
Affiliation  Institute of Teaching and Research in Ayurveda, Jamnagar 
Address  Department of Basic Principles, Opd No 11, Institute of Teaching and Research in Ayurveda, B division Police station, Near Gujarat Ayurved University, Opposite to Reliance Smart, Jamnagar.

Jamnagar
GUJARAT
361008
India 
Phone  9764271613  
Fax    
Email  dsrananavare333@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shubhangi Kamble 
Designation  Associate Professor, Dept. of Basic Principles, ITRA, Jamnagar 
Affiliation  ITRA, Jamnagar 
Address  Department of Basic Principles, Opd No 11, Institute of Teaching and Research in Ayurveda, B division Police station, Near Gujarat Ayurved University, Opposite to Reliance Smart, Jamnagar.

Jamnagar
GUJARAT
361008
India 
Phone  9428400109  
Fax    
Email  shubhangikamble@itra.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr Shubhangi Kamble 
Designation  Associate Professor, Dept. of Basic Principles, ITRA, Jamnagar 
Affiliation  ITRA, Jamnagar 
Address  Department of Basic Principles, Opd No 11, Institute of Teaching and Research in Ayurveda, B division Police station, Near Gujarat Ayurved University, Opposite to Reliance Smart, Jamnagar.

Jamnagar
GUJARAT
361008
India 
Phone  9428400109  
Fax    
Email  shubhangikamble@itra.edu.in  
 
Source of Monetary or Material Support  
Institute of Teaching and Research in Ayurveda, Jamnagar 361008 
 
Primary Sponsor  
Name  Institute of Teaching and Research in Ayurveda, Jamnagar 
Address  Institute of Teaching and Research in Ayurveda, B division Police station, Near Gujarat Ayurved University, Opposite to Reliance Smart, Jamnagar. B division Police station Near Gujarat Ayurved University Opposite to Reliance Smart Jamnagar 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shubhangi Kamble  Institute of Teaching and Research in Ayurveda Hospital  Department of Basic Principles, Opd No 11, Institute of Teaching and Research in Ayurveda, B division Police station, Near Gujarat Ayurved University, Opposite to Reliance Smart, Jamnagar.
Jamnagar
GUJARAT 
9428400109

shubhangikamble@itra.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Institute of Teaching and Research in Ayurveda, Jamnagar, Gujarat.  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L700||Acne vulgaris. Ayurveda Condition: YUVANAPIDAKA (MUKHADUSHIKA), (2) ICD-10 Condition:L449||Papulosquamous disorder, unspecified. Ayurveda Condition: YUVANAPIDAKA (MUKHADUSHIKA), (3) ICD-10 Condition:L449||Papulosquamous disorder, unspecified. Ayurveda Condition: YUVANAPIDAKA (MUKHADUSHIKA), (4) ICD-10 Condition:L55-L59||Radiation-related disorders of the skin and subcutaneous tissue. Ayurveda Condition: KSHUDRAROGAH yuvanpidika,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Mukhadushikahara Lepa, Reference: Sushruta Chikitsa 20/38, Route: Topical, Dosage Form: Lepa Churna, Dose: 10(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: Mukhadushikahara Lepa will be applied topically with conventional method.
(2) Medicine Name: Triphaladi Kashaya, Reference: Charak Chikitsa 7/100, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: Triphaladi Kashaya will be administered internally along with topical Mukhadushikahara Lepa.
2Intervention ArmDrugClassical(1) Medicine Name: Mukhadushikahara Acne Patch, Reference: Sushruta Chikitsa 20/38, Route: Topical, Dosage Form: Lepa Churna, Dose: 10(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: Mukjadushikahara Acne Patch will be prepared using these classical herbs and will be used topically
(2) Medicine Name: Triphaladi Kashaya, Reference: Charak Chikitsa 7/100, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: Triphaladi Kashaya will be administered internally along with Topical Mukhadushikahara Acne Patch.
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  30.00 Year(s)
Gender  Both 
Details  Patients having classical signs and symptoms of Mukhadushika (Acne Vulgaris) on Face. 
 
ExclusionCriteria 
Details  1. The age of patient less than 18 years and more than 30 years.
2. Patients having Mukhadushika on other parts of body.
3. Known cases of any systemic diseases like Diabetes, Cardiac diseases, Renal disorder, Hypothyroidism etc. or any viral infection.
Known cases of Carcinogenic condition of sebaceous gland.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief in the Chief Complaints of Mukhadushika (Acne Vulgaris)-Number of Pidaka (papules), Ruja (pain), Ghana pidaka (thickness), Daha (burning sensation), Srava (discharge), Medogarbha (filled with sebum) will be assessed. Number of lesions (papules/ pustules / nodular) & Area cover will be measured before and after treatment.
Severity of Acne Vulgaris will be assessed using (IGAS scale) before and after treatment. 
Baseline, 7th Day. 15th Day, 21st Day, 30th Day 
 
Secondary Outcome  
Outcome  TimePoints 
Relief in the Associated Complaints of Mukhadushika (Acne Vulgaris) viz. Shotha (Inflammation), Kandu (Itching), Snigdha Tvaka (Oily skin), Vrana Vastu (Scar), Vaivarnya (Discolouration), Shotha (Inflammation) will be assessed.
 
Baseline, 7th Day, 14th Day,21st Day, 30th Day. 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/11/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

An open labelled, randomized, comparative, parallel, two arm clinical trial has been designed for comparison of efficacy of topical application of Mukhadushikahara Acne Patch and Mukhadushikahara Lepa along with Triphaladi Kashaya as internal medicine in the management of Mukhadushika (Acne Vulgaris) for 30 days. There will be two groups with sample size 50 in either group. Primary outcome will be relief in the Chief Complaints of Mukhadushika (Acne Vulgaris) viz. Number of Pidaka (papules), Ruja (pain), Ghana pidaka (thickness), Daha (burning sensation), Srava (discharge), Medogarbha (filled with sebum). Secondary outcome will be Relief in the Associated Complaints of Mukhadushika (Acne Vulgaris) viz. Shotha (Inflammation), Kandu (Itching), Snigdha Tvaka (Oily skin), Vrana Vastu (Scar), Vaivarnya (Discolouration), Shotha (Inflammation).


In group A - Mukhadushikahara Acne Patch (external) along with Triphaladi Kashaya as internal medicine will be given for 30 days.

In group  B- Mukhadushikahara Lepa along with Triphaladi Kashaya as internal medicine will be given for 30 days.




Materials:

1.      Patients of Mukhadushika (Acne vulgaris).

2.      Trial drugs – Triphaladi Kashaya, Mukhadushikahara lepa, Mukhadushikahara Acne Patch.

 
Close